Ligand Pharmaceuticals Incorporated (35) | Stock Agreements (5)
Recent Contracts
-
Director Compensation and Stock Ownership Policy, as amended and restated, effective April 13, 2020
(Filed With SEC on February 28, 2023)
-
Form of Stock Option Agreement under the Companys 2022 Employment Inducement Plan
(Filed With SEC on August 9, 2022)
-
Form of Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan
(Filed With SEC on August 9, 2022)
-
Contingent Value Rights Agreement, dated as of September 30, 2020, by and between Ligand Pharmaceuticals Incorporated and American Stock Transfer & Trust Company, LLC
(Filed With SEC on November 6, 2020)
-
Amended and Restated Director Compensation and Stock Ownership Policy, effective March 28, 2019
(Filed With SEC on February 27, 2020)